Accumulation of somatic mutations in proliferating T cell clones from children treated for leukemia
- PMID: 11753611
- DOI: 10.1038/sj.leu.2402306
Accumulation of somatic mutations in proliferating T cell clones from children treated for leukemia
Abstract
There is continued controversy as to the sequential steps and mechanism(s) responsible for the in vivo acquisition of multiple mutations during neoplastic transformation. We investigated the in vivo clonality and mutational spectra of hypoxanthine-guanine phosphoribosyltransferase (HPRT) mutations in T cells from children with acute lymphocytic leukemia (ALL) to gain insight into the mutagenic mechanisms associated with leukemogenesis. We observed several instances of multiple, independent HPRT mutations accumulating in vivo in T cell receptor (TCR) gene defined clones that had undergone extensive pre- and/or post-thymic expansion following chemotherapy. In addition, we also detected the accumulation of multiple unique single mutations within distinct expanding post-thymic T cell clones. This pattern of clonally restricted hypermutability is compatible with extensive cell proliferation and selection alone without postulating genomic instability. These observations provide a paradigm for a continuum of cellular events that eventually results in the clonal accumulation of mutations in selected populations of cells in vivo and may provide insight into the primary genetic events associated with leukemogenesis, as well as the development of second malignancies and drug resistance following chemotherapy.
Similar articles
-
Emergence of genetic instability in children treated for leukemia.Science. 2000 Apr 21;288(5465):514-7. doi: 10.1126/science.288.5465.514. Science. 2000. PMID: 10775110
-
HPRT mutations in humans: biomarkers for mechanistic studies.Mutat Res. 2001 Oct;489(1):1-16. doi: 10.1016/s1383-5742(01)00064-3. Mutat Res. 2001. PMID: 11673087 Review.
-
V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.Cancer Res. 1996 Mar 15;56(6):1405-12. Cancer Res. 1996. PMID: 8640832
-
Hypoxanthine-guanine phosphoribosyltransferase reporter gene mutation for analysis of in vivo clonal amplification in patients with HTLV type 1-associated Myelopathy/Tropical spastic paraparesis.AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1747-52. doi: 10.1089/08892220050193254. AIDS Res Hum Retroviruses. 2000. PMID: 11080821
-
hprt mutations in vivo in human T-lymphocytes: frequencies, spectra and clonality.Prog Clin Biol Res. 1990;340C:15-24. Prog Clin Biol Res. 1990. PMID: 2199976 Review. No abstract available.
Cited by
-
Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H.Leuk Res. 2008 Aug;32(8):1268-78. doi: 10.1016/j.leukres.2007.12.015. Epub 2008 Feb 14. Leuk Res. 2008. PMID: 18279955 Free PMC article.
-
Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells.Mutat Res Rev Mutat Res. 2022 Jan-Jun;789:108414. doi: 10.1016/j.mrrev.2022.108414. Epub 2022 Mar 11. Mutat Res Rev Mutat Res. 2022. PMID: 35690417 Free PMC article. Review.
-
Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.Cancer Res. 2009 Sep 1;69(17):7004-12. doi: 10.1158/0008-5472.CAN-09-0451. Epub 2009 Aug 25. Cancer Res. 2009. PMID: 19706768 Free PMC article.
-
Models of carcinogenesis: an overview.Carcinogenesis. 2010 Oct;31(10):1703-9. doi: 10.1093/carcin/bgq087. Epub 2010 Apr 29. Carcinogenesis. 2010. PMID: 20430846 Free PMC article. Review.
-
A new timepiece: an epigenetic mitotic clock.Genome Biol. 2016 Oct 19;17(1):216. doi: 10.1186/s13059-016-1085-y. Genome Biol. 2016. PMID: 27760549 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous